The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award
Lotte Bjerre Knudsenfor their groundbreaking contributions to the understanding and therapeutic application of glucagon-like peptide-1 (GLP-1) in the treatment of obesity.This recognition not only highlights their individual achievements but also underscores a significant shift in the landscape of metabolic disease treatment.The work of these researchers serves as a model for how basic science can translate into impactful clinical therapies, ultimately enhancing patient care and improving public health outcomes.
Authors
- Yunping Zhou (ORCID: https://orcid.org/0000-0001-6132-7590)
- Yue Wang (ORCID: https://orcid.org/0000-0003-4536-9904)
- Jin‐Kui Yang (ORCID: https://orcid.org/0000-0002-5430-2149)
- Yu‐Ying Lu (ORCID: https://orcid.org/0000-0002-9776-2997)
- Qi Li
- Li-Guo Wang
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
Publication Details
- Journal
- Current Medicine
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1007/s44194-024-00041-w
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China